Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Moran

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|May 20, 2017
Technologies for Deciphering Epigenomic DNA PatternsSebastian Moran
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2018
Infinium DNA Methylation Microarrays on Formalin-Fixed, Paraffin-Embedded SamplesSebastian Moran, Manel Esteller
Epigenomics|December 18, 2015
Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequencesSebastian Moran, Carles Arribas, Manel Esteller
Epigenetics|December 22, 2012
Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner syndromeHolger Heyn, Sebastian Moran, Manel Esteller
The Lancet. Oncology|March 9, 2017
Journal club: epigenetic profiling to classify cancer of unknown primary - Authors' replySebastian Moran, Anna Martínez-Cardús, Manel Esteller
The Journal of Sports Medicine and Physical Fitness|January 14, 2017
Rates and risk factors of injury in CrossFitTM: a prospective cohort studySebastian Moran, Harry Booker, Jacob Staines, et al.
Annals of Translational Medicine|October 22, 2015
Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceAnna Martinez-Cardús, Miguel Vizoso, Sebastian Moran, et al.
Epigenetics|May 20, 2011
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genomeJuan Sandoval, Holger Heyn, Sebastian Moran, et al.
Epigenetics|July 6, 2017
Profiling of oxBS-450K 5-hydroxymethylcytosine in human placenta and brain reveals enrichment at imprinted lociJose Ramon Hernandez Mora, Marta Sanchez-Delgado, Paolo Petazzi, et al.
Oncotarget|August 25, 2018
Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of <i>AKT1</i> mutant cellsPol Gimenez-Xavier, Eva Pros, Ana Aza, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|May 20, 2017
Technologies for Deciphering Epigenomic DNA PatternsSebastian Moran
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2018
Infinium DNA Methylation Microarrays on Formalin-Fixed, Paraffin-Embedded SamplesSebastian Moran, Manel Esteller
Epigenomics|December 18, 2015
Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequencesSebastian Moran, Carles Arribas, Manel Esteller
Epigenetics|December 22, 2012
Aberrant DNA methylation profiles in the premature aging disorders Hutchinson-Gilford Progeria and Werner syndromeHolger Heyn, Sebastian Moran, Manel Esteller
The Lancet. Oncology|March 9, 2017
Journal club: epigenetic profiling to classify cancer of unknown primary - Authors' replySebastian Moran, Anna Martínez-Cardús, Manel Esteller
The Journal of Sports Medicine and Physical Fitness|January 14, 2017
Rates and risk factors of injury in CrossFitTM: a prospective cohort studySebastian Moran, Harry Booker, Jacob Staines, et al.
Annals of Translational Medicine|October 22, 2015
Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceAnna Martinez-Cardús, Miguel Vizoso, Sebastian Moran, et al.
Epigenetics|May 20, 2011
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genomeJuan Sandoval, Holger Heyn, Sebastian Moran, et al.
Epigenetics|July 6, 2017
Profiling of oxBS-450K 5-hydroxymethylcytosine in human placenta and brain reveals enrichment at imprinted lociJose Ramon Hernandez Mora, Marta Sanchez-Delgado, Paolo Petazzi, et al.
Oncotarget|August 25, 2018
Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of <i>AKT1</i> mutant cellsPol Gimenez-Xavier, Eva Pros, Ana Aza, et al.
Pageof 7